Why is JFL Life falling/rising?

As of 18-Sep, JFL Life Sciences Ltd's stock price is currently at 13.50, reflecting a decrease of 0.15 or 1.1%. The stock has underperformed its sector today by 2.15%, with a delivery volume that has fallen by 16.67% compared to the 5-day average, indicating a decline in investor participation. Although the stock has shown a positive return of 3.45% over the past week and 3.85% over the past month, it has suffered significantly over the longer term, with a staggering decline of 80.32% year-to-date. The company has reported a healthy long-term growth rate in operating profit of 34.76%, but this is overshadowed by a flat performance in recent quarters, including a notable drop in net sales.
In the broader market context, while the Sensex has gained 1.67% over the past week and 2.20% over the past month, JFL Life's performance has been lackluster, particularly in the long term, where it has underperformed the BSE500 index over the last three years, one year, and three months. The stock's return on capital employed (ROCE) of 14.4 suggests an attractive valuation, yet the significant decline in stock price and flat results in recent quarters raise concerns about its future performance. Overall, despite some positive indicators, the prevailing negative trends and underperformance relative to the market contribute to the stock's current downward trajectory.